Not Enough Beds To Go Around To Meet Asia’s Rising Demand For Medical Tourism
This article was originally published in PharmAsia News
Executive Summary
Frost & Sullivan weighs in on the state of medical tourism in southeast Asia, where some countries see greater opportunities for public-private partnerships.
You may also be interested in...
Cost Of China Healthcare Reforms Exceeds RMB 1 Trillion; Government Raises Reimbursement Ceilings
BEIJING - As leaders in China's central government gathered last week in Beijing to take part in the National People's Congress, they revealed that the price of ever-expanding healthcare reforms, ultimately aimed at providing universal coverage and commonly affordable medical care through measures including the national Essential Drug List, has already risen above RMB 1 trillion
MNCs Urge Indonesia For Exemption From Decree Requiring Local Manufacturing Facilities
Multinational companies are putting pressure on Indonesia's Ministry of Health to exempt them from a new decree requiring foreign drug companies to have local production facilities or leave Indonesia, according to Merck and Sanofi-Aventis
Indonesia Decree Requiring Foreign Drug Makers To Build Local Plants “Disastrous”
PERTH, Australia - A decree issued by Indonesia's health minister earlier this month requiring foreign drug manufacturers to build manufacturing plants in the country, or leave, would be disastrous to the industry, an industry leader said
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports